Ownership Capital B.V. Edwards Lifesciences Corp Transaction History

Ownership Capital B.V.

$1.72 Billion
Q2 2025

A detailed history of Ownership Capital B.V. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Ownership Capital B.V. holds 1,786,254 shares of EW stock, worth $130 Million. This represents 8.12% of its overall portfolio holdings.

Number of Shares

1,786,254

Previous 2,353,348 24.1%

Holding current value

$130 Million

Previous $171 Million 18.1%

% of portfolio

8.12%

Previous 7.82%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 04, 2025	SELL	$67.07 - $78.22 $38 Million - $44.4 Million	-567,094 Reduced 24.1%	1,786,254 $140 Million
Q1 2025 May 01, 2025	SELL	$67.95 - $76.19 $29.8 Million - $33.4 Million	-438,917 Reduced 15.72%	2,353,348 $171 Million
Q4 2024 Feb 03, 2025	SELL	$64.54 - $75.92 $13 Million - $15.2 Million	-200,754 Reduced 6.71%	2,792,265 $207 Million
Q3 2024 Nov 04, 2024	BUY	$59.7 - $93.78 $2.07 Million - $3.24 Million	34,597 Added 1.17%	2,993,019 $198 Million
Q2 2024 Aug 05, 2024	SELL	$84.3 - $94.31 $22.9 Million - $25.6 Million	-271,533 Reduced 8.41%	2,958,422 $273 Million
Q1 2024 May 02, 2024	SELL	$72.54 - $95.56 $18.9 Million - $24.8 Million	-259,960 Reduced 7.45%	3,229,955 $309 Million
Q4 2023 Feb 05, 2024	BUY	$61.71 - $77.76 $37.9 Million - $47.7 Million	613,817 Added 21.34%	3,489,915 $266 Million
Q3 2023 Nov 03, 2023	SELL	$69.28 - $93.38 $53.8 Million - $72.5 Million	-776,875 Reduced 21.27%	2,876,098 $199 Million
Q2 2023 Aug 02, 2023	SELL	$81.41 - $94.33 $36.8 Million - $42.6 Million	-451,579 Reduced 11.0%	3,652,973 $345 Million
Q1 2023 May 09, 2023	SELL	$74.26 - $84.51 $3.77 Million - $4.3 Million	-50,831 Reduced 1.22%	4,104,552 $340 Million
Q4 2022 Feb 07, 2023	SELL	$68.3 - $87.44 $2.16 Million - $2.76 Million	-31,556 Reduced 0.75%	4,155,383 $310 Million
Q3 2022 Oct 11, 2022	SELL	$82.37 - $107.29 $25.5 Million - $33.3 Million	-309,950 Reduced 6.89%	4,186,939 $346 Million
Q2 2022 Aug 10, 2022	BUY	$86.5 - $128.27 $16.5 Million - $24.5 Million	190,982 Added 4.44%	4,496,889 $428 Million
Q1 2022 Apr 25, 2022	BUY	$101.96 - $128.34 $23.6 Million - $29.7 Million	231,667 Added 5.69%	4,305,907 $507 Million
Q4 2021 Feb 01, 2022	SELL	$106.37 - $130.68 $106 Million - $130 Million	-992,336 Reduced 19.59%	4,074,240 $528 Million
Q3 2021 Nov 08, 2021	BUY	$102.91 - $122.75 $16.6 Million - $19.8 Million	160,960 Added 3.28%	5,066,576 $574 Million
Q2 2021 Aug 09, 2021	BUY	$83.84 - $104.76 $10 Million - $12.5 Million	119,230 Added 2.49%	4,905,616 $508 Million
Q1 2021 May 11, 2021	BUY	$78.68 - $90.67 $51.8 Million - $59.7 Million	658,447 Added 15.95%	4,786,386 $400 Million
Q4 2020 Feb 08, 2021	BUY	$71.69 - $91.23 $59.4 Million - $75.6 Million	828,870 Added 25.12%	4,127,939 $377 Million
Q3 2020 Nov 06, 2020	BUY	$67.19 - $87.44 $222 Million - $288 Million	3,299,069 New	3,299,069 $263 Million

Others Institutions Holding EW

# of Institutions

1,444

Shares Held

483M

Call Options Held

2.76M

Put Options Held

1.54M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $44.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ownership Capital B.V., based on Form 13F filings with the SEC.

News

Stay updated on Ownership Capital B.V. with notifications on news.

Account

Ownership Capital B.V. Edwards Lifesciences Corp Transaction History